Related Experiment Video
Updated: Aug 9, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Bcl-2 relieves the trans-repressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like
1Department of Genetics, National Children's Medical Research Center, Tokyo, Japan. tmiyashita@nch.go.jp
Abstract:
Glucocorticoid induces apoptosis in immature lymphocytes which is inhibitable by Bcl-2. Although glucocorticoid-mediated signal transduction is well understood, the mechanism of the induction of apoptosis by the activated glucocorticoid receptor as well as the inhibition of apoptosis by Bcl-2 remains enigmatic. Here we report that overexpressed Bcl-2 relieves the glucocorticoid receptor-mediated repressive function on the AP-1 activity and completely inhibits the activation of CPP32-like cysteine proteases. In contrast, glucocorticoid receptor-mediated transactivation was not affected by Bcl-2. This suggests that glucocorticoid may induce apoptosis by repressing transactivation by AP-1 which is relieved by Bcl-2. Furthermore, we report evidence that, in contrast with CPP32-like proteases, ICE-like proteases are not involved in this apoptotic pathway.
Insights
Glucocorticoids trigger lymphocyte apoptosis, a process inhibited by Bcl-2. This study reveals Bcl-2 prevents glucocorticoid receptor repression of AP-1, blocking apoptosis without affecting transactivation.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Glucocorticoids induce apoptosis in immature lymphocytes.
- The anti-apoptotic protein Bcl-2 can inhibit this glucocorticoid-induced cell death.
- Mechanisms underlying glucocorticoid-induced apoptosis and Bcl-2 inhibition remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which glucocorticoids induce apoptosis in lymphocytes.
- To investigate how Bcl-2 inhibits glucocorticoid-induced apoptosis.
- To determine the role of AP-1 activity and cysteine proteases in this pathway.
Main Methods:
- Overexpression of Bcl-2 in lymphocytes.
- Analysis of glucocorticoid receptor activity and AP-1 transcriptional activity.
- Assays for CPP32-like and ICE-like protease activation.
Main Results:
- Overexpressed Bcl-2 relieved glucocorticoid receptor-mediated repression of AP-1 activity.
- Bcl-2 completely inhibited the activation of CPP32-like cysteine proteases.
- Glucocorticoid receptor-mediated transactivation was unaffected by Bcl-2.
- ICE-like proteases were not involved in the apoptotic pathway.
Conclusions:
- Glucocorticoid-induced lymphocyte apoptosis may occur via repression of AP-1 transactivation, a process reversed by Bcl-2.
- Bcl-2 inhibits apoptosis by preventing AP-1 repression and CPP32-like protease activation.
- The findings clarify the roles of AP-1 and specific proteases in glucocorticoid-mediated apoptosis.
Related Concept Videos
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Caspases
The Intrinsic Apoptotic Pathway
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...

